Anika Therapeutics, Inc. (ANIK) Gross profit 2018–2025
Anika Therapeutics, Inc. (ANIK) annual gross profit history from SEC filings — each fiscal year as reported.
$63.8MFY2025 · since FY2018: $74.3M → $63.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $63.8M | -16.0% |
| FY2024 | $76.0M | -7.9% |
| FY2023 | $82.5M | +12.7% |
| FY2022 | $73.2M | -11.7% |
| FY2021 | $82.9M | +20.2% |
| FY2020 | $69.0M | -19.6% |
| FY2019 | $85.9M | +15.6% |
| FY2018 | $74.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice